Editor's Comparative Analysis
When choosing between The Lancet and ARS Medica, researchers should consider the trade-off between prestige (ARS Medica leads with an IF of ) and cost-efficiency, as ARS Medica is a Diamond Open Access venue.
The Lancet is published in NL, while ARS Medica is headquartered in CL. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | The Lancet | ARS Medica |
|---|---|---|
| General Information | ||
| Publisher | Elsevier | Pontificia Universidad Católica de Chile |
| Country of Origin | NL | CL |
| Established | 1823 | 2023 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor |
15.34
|
N/A |
| Indexing Status |
|
DOAJ
|
| Review Speed (Decision) | Unknown |
70 days
Standard
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Hybrid | Full OA |
| APC Fee (Estimated) | $6,500.00 | FREE (Diamond) |
Historical Impact Factor Comparison
About The Lancet
The Lancet is a prominent academic journal specializing in Clinical Medicine and Medicine. Published by Elsevier in NL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0140-6736. With a current impact factor of 15.342, The Lancet …
View Full ProfileAbout ARS Medica
ARS Medica is a prominent academic journal specializing in Medicine. Published by Pontificia Universidad Católica de Chile in CL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 0718-1051. The journal aims to advance the boundaries …
View Full ProfileSearching for: The Lancet impact factor, ARS Medica APC fees, journal comparison tool 2026.